P2Y12 Inhibitor Monotherapy Versus Long-term Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: a Meta-analysis of Randomized Controlled Trials

Overview

Journal Arch Med Sci Atheroscler Dis

Date 2025 Feb 26

PMID 40007981

Authors

Mushood Ahmed

Areeba Ahsan

Priyansha Singh

Adeel Ahmad

Hritvik Jain

Asad Rahman

Sohail Q Khan

Raheel Ahmed

Mahboob Alam

Farhan Shahid

Affiliations

Soon will be listed here.

References

Mehran R, Baber U, Sharma S, Cohen D, Angiolillo D, Briguori C . Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med. 2019; 381(21):2032-2042. DOI: 10.1056/NEJMoa1908419. View

Genereux P, Giustino G, Witzenbichler B, Weisz G, Stuckey T, Rinaldi M . Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2015; 66(9):1036-45. DOI: 10.1016/j.jacc.2015.06.1323. View

Ge Z, Kan J, Gao X, Raza A, Zhang J, Mohydin B . Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial. Lancet. 2024; 403(10439):1866-1878. DOI: 10.1016/S0140-6736(24)00473-2. View

Hahn J, Song Y, Oh J, Chun W, Park Y, Jang W . Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial. JAMA. 2019; 321(24):2428-2437. PMC: 6593635. DOI: 10.1001/jama.2019.8146. View

Valgimigli M, Bueno H, Byrne R, Collet J, Costa F, Jeppsson A . 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the.... Eur Heart J. 2017; 39(3):213-260. DOI: 10.1093/eurheartj/ehx419. View

Vranckx P, Valgimigli M, Juni P, Hamm C, Steg P, Heg D . Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre,.... Lancet. 2018; 392(10151):940-949. DOI: 10.1016/S0140-6736(18)31858-0. View

Amsterdam E, Wenger N, Brindis R, Casey Jr D, Ganiats T, Holmes Jr D . 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 64(24):e139-e228. DOI: 10.1016/j.jacc.2014.09.017. View

Kim B, Hong S, Cho Y, Yun K, Kim Y, Suh Y . Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial. JAMA. 2020; 323(23):2407-2416. PMC: 7298605. DOI: 10.1001/jama.2020.7580. View

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T . Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. JAMA. 2019; 321(24):2414-2427. PMC: 6593641. DOI: 10.1001/jama.2019.8145. View

10.

Ahmed M, Javaid H, Maniya M, Shafiq A, Shahbaz H, Singh P . Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention: A meta-analysis of randomized controlled trials. Int J Cardiol Heart Vasc. 2024; 52:101405. PMC: 11156695. DOI: 10.1016/j.ijcha.2024.101405. View

11.

Levine G, Bates E, Bittl J, Brindis R, Fihn S, Fleisher L . 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update.... Circulation. 2016; 134(10):e123-55. DOI: 10.1161/CIR.0000000000000404. View

12.

Baber U, Dangas G, Chandrasekhar J, Sartori S, Steg P, Cohen D . Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. JACC Cardiovasc Interv. 2016; 9(13):1349-57. DOI: 10.1016/j.jcin.2016.04.009. View

13.

OGara P, Kushner F, Ascheim D, Casey Jr D, Chung M, de Lemos J . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012; 127(4):529-55. DOI: 10.1161/CIR.0b013e3182742c84. View

14.

Ahmed M, Zahra R, Ahsan A, Nadeem Z, Singh P, Fatima S . Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in patients with unprotected left main coronary artery disease: a systematic review and meta-analysis of randomized controlled trials and propensity.... Arch Med Sci Atheroscler Dis. 2024; 9:e82-e85. PMC: 11155459. DOI: 10.5114/amsad/188269. View

15.

Mauri L, Kereiakes D, Yeh R, Driscoll-Shempp P, Cutlip D, Steg P . Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014; 371(23):2155-66. PMC: 4481318. DOI: 10.1056/NEJMoa1409312. View